View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Damien Choplain ... (+3)
  • Damien Choplain
  • Maria Vara
  • Oscar Haffen Lamm

End of coverage

From 5th August 2025, we will no longer include the following companies in our coverage:EVOTECMEDIOSDBV Technologies

 PRESS RELEASE

Information regarding the total number of voting rights and total numb...

Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025 Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)   Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights    07/31/2025      136,975,159     Total gross of voting rights: 136,975,159 Total net* of voting rights: 136,810,568 * Net t...

 PRESS RELEASE

Information relative au nombre total des droits de vote et d’actions ...

Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2025 Information relative au nombre total des droits de vote etd’actions composant le capital social au 31 juillet 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code ISIN : FR 0010417345 Date Nombre totald’actionscomposant le capital social Nombre total de droits de vote     31/07/2025       136.975.159   Total brut des droits de vote : ...

 PRESS RELEASE

DBV Technologies announces filing of 2025 Half-Year Report ― Condition...

DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report Châtillon, France, July 29, 2025 DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “Company”), today announced the filing, for the semester ended June 30, 2025, of its Half-Y...

 PRESS RELEASE

DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modali...

DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation Châtillon, France, le 29 juillet 2025 DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société biopharmaceutique au stade clinique (la « Société »), a annoncé aujourd'hui que son Rapport Financier Semestriel 2025 (le « RFS ») a été déposé auprès de l’Autorité des Marchés Financiers (« AMF ») en France. Le RFS au 30 juin 2025 peut êtr...

 PRESS RELEASE

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial R...

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today reported financial results for the Second Quarter of 2025. The quarterly and half-year financial statements were approved by the Board of Directors on July 29, 2025. Financial Highlights for the Second Quarter Ended June 30, 2025The Company’s interim con...

 PRESS RELEASE

DBV Technologies publie ses résultats financiers du 2ème trimestre et ...

DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 Châtillon, France, le 29 juillet 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : 23306J309), société biopharmaceutique au stade clinique, publie aujourd'hui ses résultats financiers du deuxième trimestre 2025. Les états financiers trimestriels et semestriels ont été approuvés par le Conseil d'Administration le 29 juillet 2025. Résultats financiers pour le semestre c...

 PRESS RELEASE

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO ...

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF AMF Regulated InformationChâtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today issued the Half-Year report on its liquidity contract with ODDO BHF. Under the liquidity contract between DBV Technologies and ODDO BHF, the following assets appeared on the liquidity account as of June 30, 2025: 210,069 DBV Technologies shares,€ 171,30...

 PRESS RELEASE

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BH...

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF Informations RéglementéesChâtillon, France, le 28 juillet (22 h 30 CET) 2025 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), laboratoire biopharmaceutique français, publie aujourd’hui le bilan semestriel de son contrat de liquidité avec ODDO BHF. Au titre du contrat de liquidité confié à ODDO BHF, portant sur les actions de la société DBV TECHNOLOGIES, à la date du 30 juin 2025, les moyens suivants figuraient au compte de...

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
 PRESS RELEASE

DBV Technologies Announces Appointment of James Briggs as Chief Human ...

DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer Châtillon, France, July 22, 2025 DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, today announced the appointment of James Briggs as its Chief Human Resources Officer, succeeding Caroline Daniere. An experienced human capital executive, James will lead key initiatives as DBV transitions from a development-stage biotechnology company to a potent...

 PRESS RELEASE

DBV Technologies annonce la nomination de James Briggs au poste de Dir...

DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines Châtillon, France, le 22 juillet (22 :30 CEST) 2025 DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT— CUSIP: 23306J309), une société biopharmaceutique au stade clinique, a annoncé aujourd'hui la nomination de James Briggs au poste de Directeur des Ressources Humaines, succédant à Caroline Daniere. Dirigeant expérimenté dans le domaine des ressources humaines...

 PRESS RELEASE

DBV Technologies Announces First Subject Screened in COMFORT Toddlers ...

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old Châtillon, France, June 25, 2025 DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old First subject screened at the Respiratory Medicine Research Institute of Michigan with Dr. Jeffrey Leflein acting as Principal InvestigatorAdditional sites, including Allergy and Asthma Center of Minnesota and Hamilton Allergy and Immunology Clinic of Ontario, Canada have been act...

 PRESS RELEASE

DBV Technologies annonce le screening du premier sujet de l'étude comp...

DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide. Châtillon, France, le 25 juin (22 :30 CEST) 2025 DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide. Screening du premier sujet à l'Institut de recherche en médecine respiratoire du Michigan, sous la direction du Dr Jeffrey Leflein, investigateur principal.D'autres sites ont été activés et prévoient des...

Jeremy Garnier
  • Jeremy Garnier

ODDO : ODDO BHF Nextcap Forum: Feedback from day two

Feedback of the companies present at the ODDO BHF Nextcap Forum Company Country Market cap. (m) Company Country Market cap. (m) Accsys Technologies € 124 Hoffmann Green € 62 Afyren € 72 Hornbach € 1 451 Altri € 1 058 IDI € 537 AMG € 550 Implenia CHF 973 AmRest PLN 3 544 Jacquet Metals € 494 Arcure € 29 Kloeckner & Co € 653 Arverne 194 Knaustabbert € 144 Austriacard Holdings € 188 Lna Santé € 270 Bastide € 218 Medincell € 398 Befesa € 1 116 Nacon € 63 CAF € 1 649 N...

Jeremy Garnier
  • Jeremy Garnier

ODDO : ODDO BHF Nextcap Forum 2025: Feedback

Our 14th edition of the ODDO BHF Nextcap Forum took place on 11 June in Paris, and on 12 June virtually. 96 companies and 170 investors were present for more than 700 meetings organized. Overall, we noted a still cautious tone from companies, with limited visibility on a solid rebound in a persistently uncertain market environment (geopolitical situation, US politics, etc.), even if there are some signs of recovery and certain sectors remain very well positioned (leisure, energy, defence). At th...

Bruno Cavalier ... (+2)
  • Bruno Cavalier
  • Jeremy Garnier
SCHP SECHE ENVIRONNEMENT
FP TOTAL SE
TKA THYSSENKRUPP AG
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
ALLIX WALLIX GROUP SA
MC LVMH MOET HENNESSY LOUIS VUITTON SE
SSAB A SSAB AB CLASS A
NXI NEXITY SA CLASS A
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
DBG DERICHEBOURG SA
INF INFOTEL SA
FGA FIGEAC AERO SA
UNIQA INSURANCE GROUP AG
ASY ASSYSTEM SA
EL ESSILORLUXOTTICA SA
BLC BASTIDE LE CONFORT MEDICAL SA
KCO KLOECKNER & CO SE
ALTR ALTRI SGPS SA
SWP SWORD GROUP SE
CGM CEGEDIM SA
BRBY BURBERRY GROUP PLC
AUB AUBAY SA
EKI EKINOPS SA
VLS VALNEVA SE
MRN MERSEN SA
FII LISI SA
LSS LECTRA SA
LNA LNA SANTE SA
JCQ JACQUET METALS SA
GOE GROUPE GORGE SA
CDA COMPAGNIE DES ALPES SA
KER KERING SA
ELG ELMOS SEMICONDUCTOR SE
ALCAR CARMAT SA
TPE PVA TEPLA AG
ENI ENI S.P.A.
QDT QUADIENT SA
01913 PRADA S.P.A.
IMPN IMPLENIA AG
REP REPSOL SA
IDIP INSTITUT DE DEVELOPPEMENT INDUSTRIEL SCA
DEZ DEUTZ AG
COR CORTICEIRA AMORIM SGPS SA
TUB TUBACEX S.A.
HEIJM HEIJMANS N.V. CERT
PAL
RIEN PALFINGER AG
AMG RIETER HOLDING AG
MONC AMG ADVANCED METALLURGICAL GROUP N.V.
EDR MONCLER SPA
ALBFR EDREAMS ODIGEO SA
ZAG SIDETRADE SA
POST ZUMTOBEL GROUP AG
LTA OSTERREICHISCHE POST AG
BC ALTAMIR ACT PORTEUR
CFR BRUNELLO CUCINELLI S.P.A.
FACC COMPAGNIE FINANCIERE RICHEMONT SA
AXS FACC AG
HBH ACCSYS TECHNOLOGIES
DKG HORNBACH HOLDING AG & CO. KGAA
TRE DEUTSCHE KONSUM REIT-AG
FTG111 TECNICAS REUNIDAS SA
BP. FLATEXDEGIRO AG
SMCP BP P.L.C.
BFSA SMCP SA
VOS BEFESA SA
CAF VOSSLOH AG
MEDCL CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
EAT MEDINCELL SA
WAVE AMREST HOLDINGS SE
GRE WAVESTONE SA
THEP GRENERGY RENOVABLES
ALCUR THERMADOR HOLDING SA
FQT ARCURE SA
CLA FREQUENTIS AG WIENER
S30 CLARANOVA SE
ALHGR SOLUTIONS 30 SE
NACON HOFFMANN GREEN CEMENT TECHNOLOGIES SA
DSC1 NACON SASU
KTA DUTCH STAR C SHAR
UPG KNAUS TABBERT
ALAFY UNIFIEDPOST GROUP
FORSE AFYREN
WAGA FORSEE POWER SA
SHEL WAGA ENERGY SA
EAPI SHELL PLC
ACAG EUROAPI
ARVEN AUSTRIACARD HOLDINGS AG
ORP ARVERNE GROUP SA
VIRI ORPEA
LOCAL VIRIDIEN
SOLOCAL GROUP
Bruno Cavalier ... (+2)
  • Bruno Cavalier
  • Jeremy Garnier
SCHP SECHE ENVIRONNEMENT
FP TOTAL SE
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
ALLIX WALLIX GROUP SA
DGE DIAGEO PLC
RNO RENAULT SA
MC LVMH MOET HENNESSY LOUIS VUITTON SE
RI PERNOD RICARD SA
NXI NEXITY SA CLASS A
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
RCO REMY COINTREAU SA
DBG DERICHEBOURG SA
INF INFOTEL SA
UNIQA INSURANCE GROUP AG
ASY ASSYSTEM SA
EL ESSILORLUXOTTICA SA
OMV OMV AG
BLC BASTIDE LE CONFORT MEDICAL SA
KCO KLOECKNER & CO SE
ALTR ALTRI SGPS SA
SWP SWORD GROUP SE
CGM CEGEDIM SA
BRBY BURBERRY GROUP PLC
AUB AUBAY SA
EKI EKINOPS SA
VLS VALNEVA SE
MRN MERSEN SA
FII LISI SA
LSS LECTRA SA
LNA LNA SANTE SA
JCQ JACQUET METALS SA
GOE GROUPE GORGE SA
CDA COMPAGNIE DES ALPES SA
KER KERING SA
ELG ELMOS SEMICONDUCTOR SE
ALCAR CARMAT SA
ENI ENI S.P.A.
PZU POWSZECHNY ZAKLAD UBEZPIECZEN SPOLKA AKCYJNA
QDT QUADIENT SA
01913 PRADA S.P.A.
IMPN IMPLENIA AG
REP REPSOL SA
IDIP INSTITUT DE DEVELOPPEMENT INDUSTRIEL SCA
DEZ DEUTZ AG
COR CORTICEIRA AMORIM SGPS SA
TUB TUBACEX S.A.
HEIJM HEIJMANS N.V. CERT
PAL
RIEN PALFINGER AG
AMG RIETER HOLDING AG
MONC AMG ADVANCED METALLURGICAL GROUP N.V.
EDR MONCLER SPA
ALBFR EDREAMS ODIGEO SA
ZAG SIDETRADE SA
POST ZUMTOBEL GROUP AG
BC OSTERREICHISCHE POST AG
CFR BRUNELLO CUCINELLI S.P.A.
FACC COMPAGNIE FINANCIERE RICHEMONT SA
AXS FACC AG
HBH ACCSYS TECHNOLOGIES
TRE HORNBACH HOLDING AG & CO. KGAA
BP. TECNICAS REUNIDAS SA
SMCP BP P.L.C.
BFSA SMCP SA
VOS BEFESA SA
CAF VOSSLOH AG
MEDCL CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
EAT MEDINCELL SA
WAVE AMREST HOLDINGS SE
GRE WAVESTONE SA
THEP GRENERGY RENOVABLES
ALCUR THERMADOR HOLDING SA
FQT ARCURE SA
CLA FREQUENTIS AG WIENER
S30 CLARANOVA SE
ALHGR SOLUTIONS 30 SE
NACON HOFFMANN GREEN CEMENT TECHNOLOGIES SA
DSC1 NACON SASU
CPR DUTCH STAR C SHAR
KTA DAVIDE CAMPARI-MILANO N.V.
UPG KNAUS TABBERT
ALAFY UNIFIEDPOST GROUP
FORSE AFYREN
WAGA FORSEE POWER SA
SHEL WAGA ENERGY SA
EAPI SHELL PLC
ACAG EUROAPI
ARVEN AUSTRIACARD HOLDINGS AG
ORP ARVERNE GROUP SA
VIRI ORPEA
LOCAL VIRIDIEN
SOLOCAL GROUP
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch